Are you Dr. Vandendries?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 50 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
200 West St
Waltham, MA 02451Phone+1 781-434-4463
Summary
- Dr. Erik Vandendries, MD is an oncologist in Waltham, Massachusetts. He is currently licensed to practice medicine in Massachusetts.
Education & Training
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1995 - 1998
- Albert Einstein College of MedicineClass of 1995
Certifications & Licensure
- MA State Medical License 2000 - 2025
Publications & Presentations
PubMed
- 31 citationsA phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma.Nina D. Wagner-Johnston, Andre Goy, Maria Alma Rodriguez, W. Christopher Ehmann, Paul A. Hamlin
Leukemia & Lymphoma. 2015-02-24 - 51 citationsRandomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphomaNam H. Dang, Michinori Ogura, Sylvie Castaigne, Luis Fayad, Mats Jerkeman
British Journal of Haematology. 2018-08-01 - 246 citationsSafety, Pharmacokinetics, and Preliminary Clinical Activity of Inotuzumab Ozogamicin, a Novel Immunoconjugate for the Treatment of B-Cell Non-Hodgkin's Lymphoma: Resul...Anjali S. Advani, Bertrand Coiffier, Myron S. Czuczman, Martin Dreyling, James M. Foran
Journal of Clinical Oncology. 2010-04-20